Health

Latest Health News

đź“…February 22, 2026 at 1:00 AM
Global health advances in gene delivery, flu vaccines, AI data analysis, HIV research, and treatments for ulcerative colitis, hepatitis C, amid policy challenges.
1

New Neutral Molecule Revolutionizes DNA Delivery into Cells

Researchers from Tokyo Metropolitan University developed a charge-free 'single nucleobase-terminal complex (SNTC)' using PEG and thymine to deliver DNA into cells without inflammation. Experiments in mice showed up to 14-fold increased DNA uptake compared to naked DNA, promising safer gene therapies and vaccines.Source 2 Published January 16, 2026, in ACS Applied Bio Materials.

2

WHO: Next-Generation Flu Vaccines Could Prevent 18 Billion Cases

The WHO's Full Value of Improved Influenza Vaccine Assessment (FVIVA) indicates next-generation vaccines could avert up to 18 billion influenza cases worldwide. This highlights potential to save millions of lives through enhanced vaccine efficacy.Source 3 The assessment emphasizes global impact on pandemic preparedness.

3

TREMFYA Shows Sustained Remission in Ulcerative Colitis Over 3 Years

Johnson & Johnson's TREMFYA (guselkumab) achieved 78% histo-endoscopic mucosal improvement in ulcerative colitis patients, with sustained clinical and endoscopic remission through three years. The dual-acting IL-23 inhibitor reduces flare-ups and surgery needs.Source 6 Data announced February 21, 2026.

4

Generative AI Outpaces Human Teams in Medical Data Analysis

UC San Francisco researchers found generative AI processes complex medical datasets, like preterm birth prediction from 1,000+ pregnancies, faster than human teams, generating code in minutes. Junior researchers matched expert results, accelerating discoveries.Source 8 Study dated February 21, 2026.

5

CROI 2026 Highlights HIV Cure Progress, Drug Resistance, and GLP-1 Use

The Conference on Retroviruses and Opportunistic Infections (CROI 2026), starting February 22 in Denver, features lectures on 30-year HIV cure efforts, Trump-era science policy assaults, and prevention advances. Key themes include INSTI resistance, GLP-1 for weight loss, and complications like CVD and TB.Source 5 Hybrid event addresses funding cuts.

6

At-Risk Groups Lag in Global Hepatitis C Elimination Efforts

A systematic review shows people living with HIV (PLHIV), people who inject drugs (PWID), men who have sex with men (MSM), and incarcerated individuals falling behind in HCV care cascades. This hinders WHO's elimination goals.Source 9 Meta-analysis underscores need for targeted interventions.

7

Stronger Muscles in Older Women Linked to Longer Life

Analysis reveals stronger muscles correlate with increased lifespan in older women, part of recent dermatology and health recaps. This supports muscle health as a longevity factor.Source 4 Included in February 15-20 Rx Recap.

8

India Launches AI-Accelerated Genomics and Gene Therapy Collaboration

Dr. Jitendra Singh announced public-private partnerships advancing AI in genomics, gene therapy, and precision medicine to transform Indian healthcare. Initiative steps into next-era health tech.Source 13 Focuses on accelerating research and treatments.

9

Neurologists Lobby for Brain Health Funding on Capitol Hill

200 neurologists from 47 states urge lawmakers in Washington, D.C., to fund lifesaving brain health research and policies. 'Neurology on the Hill' aims to improve outcomes for neurological conditions.Source 10 Event emphasizes federal support needs.

10

US and WHO Strengthen Global Health Security Post-COVID

Recent updates highlight US recommitment to WHO-led pandemic preparedness, early warning systems, equitable vaccines, and research into antivirals and non-communicable diseases like cancer. Challenges include funding and geopolitics.Source 1 Focus on dynamic health threat adaptation.

11

Ontarians Without Family Doctors Face Higher Death Risk

University of Ottawa research shows individuals without a family doctor in Ontario have elevated mortality risk compared to those with primary care attachment. Highlights access disparities in healthcare.Source 12 New study impacts policy discussions.

12

First-in-World Subcutaneous Blinatumomab Trial for Rare Leukemia

Global first trial explores subcutaneous blinatumomab administration in rare leukemia cases, part of key health takeaways. Aims to improve treatment delivery.Source 4 Featured in February 15-20 health recap.